- Forums
- ASX - By Stock
- AGN
- Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers, page-19
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
78.5¢ |
Change
0.010(1.29%) |
Mkt cap ! $99.27M |
Open | High | Low | Value | Volume |
77.5¢ | 80.0¢ | 77.0¢ | $107.8K | 137.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2679 | 78.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
79.0¢ | 10881 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2679 | 0.780 |
2 | 6260 | 0.775 |
2 | 16215 | 0.770 |
1 | 1307 | 0.765 |
2 | 13128 | 0.760 |
Price($) | Vol. | No. |
---|---|---|
0.790 | 10881 | 3 |
0.795 | 20861 | 2 |
0.800 | 46089 | 1 |
0.805 | 1208 | 1 |
0.830 | 10000 | 1 |
Last trade - 13.02pm 12/11/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online